Skip to search formSkip to main contentSkip to account menu

AZD 7009

Known as: AZD-7009, AZD7009 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Atrial fibrillation (AF) is the most common tachyarrhythmia in the adult population and is a major cause of morbidity and… 
2006
2006
This study evaluated the effects of the novel antiarrhythmic agent AZD7009 on atrial and ventricular repolarization and on the Na… 
2006
2006
AIMS To compare the electrophysiological and antiarrhythmic effects of AZD7009, azimilide, and AVE0118 in the acutely dilated… 
Highly Cited
2005
Highly Cited
2005
Introduction: AZD7009 is a novel anti‐arrhythmic compound under development for short‐ and long‐term management of atrial… 
2005
2005
Background: This study examined the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide. 
2005
2005
AZD7009 is a novel antiarrhythmic compound in early clinical development for management of atrial fibrillation… 
Highly Cited
2004
Highly Cited
2004
INTRODUCTION We tested the hypothesis that AZD7009 terminates induced atrial fibrillation (AF) and flutter (AFL) and prevents…